RSS Feed
Article
Celldex Targeted Drug Shrinks Breast Cancer
CDX-011 works best in breast cancers with high levels of a protein linked to more aggressive disease.
04:01PM 05/23/12
Article
Galena Biopharma's Breast Cancer Vaccine Sprouts More Red Flags
Galena has questions that need answering about its breast cancer vaccine NeuVax at the upcoming ASCO confab.
02:23PM 05/22/12
Article
22 Biopharma Stocks With Breakout Potential in 2012
TheStreet's Adam Feuerstein has compiled a list of drugs with crucial, stock-moving clinical trial catalysts for the remainder of 2012.
08:56AM 05/22/12
Article
Biotech Stock Live Chat Recap: ASCO & Obesity
TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech stock investing.
11:55AM 05/17/12
Article
ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update)
Array Biopharma, Exelixis,Onyx Pharma and Pharmacyclics among cancer drug developers releasing new data ahead of the big ASCO meeting.
06:19AM 05/17/12
Article
Pfizer, Glaxo, J&J Grab ASCO Spotlight
New drugs that target genetic weakness in cancer in the spotlight as ASCO previews its closely followed conference.
06:01PM 05/16/12
Article
ASCO '12 Abstract Dump: Cancer Stocks in Focus
Array Biopharma, Exelixis, Aveo and Pharmacyclics among cancer drug developers releasing new data ahead of the big ASCO meeting.
06:00PM 05/16/12
Article
Hot Biotech Stocks Traded by Hedge Funds in First Quarter
A closer look at 13F regulatory filings in the biotech sector for the first quarter.
07:10AM 05/16/12
Article
Mulling Arena Pharma's Future With Obesity Drug on Approval Path
Thoughts and questions following last week's positive FDA panel for Arena's weight-loss drug lorcaserin.
03:09PM 05/14/12
Article
Arena Pharma: FDA Panel Live Blog
Join TheStreet biotech columnist Adam Feuerstein as he provides live coverage of the FDA advisory panel reviewing Arena Pharma's obesity drug lorcaserin.
07:43AM 05/10/12
Connect with TheStreet